|
End-of-day quote
Shenzhen S.E.
14/05/2026
|
5-day change
|
1st Jan Change
|
|
63.81 CNY
|
+0.19%
|
 |
+6.71%
|
+11.67%
|
|
04-23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2026
|
CI
| |
03-12 |
Soochow Securities Starts Hangzhou Bio-Sincerity Pharma-Tech at Buy
|
MT
| |
12-21 |
Certain A Shares of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-DEC-2025.
|
CI
| |
24/10/25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
26/08/25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
22/04/25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
22/04/25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
|
CI
| |
10/02/25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Board Elections
|
CI
| |
20/12/24 |
Certain A Shares of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-DEC-2024.
|
CI
| |
28/10/24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
|
CI
| |
14/08/24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
|
CI
| |
27/05/24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Announces Cash Dividend for the Year 2023, Payable on 3 June 2024
|
CI
| |
22/04/24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| |
21/12/23 |
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
|
CI
| |
19/12/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback announced on August 24, 2023, has closed with 777,300 shares, representing 0.72% for CNY 49.99 million,
|
CI
| |
25/10/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
|
CI
| |
10/10/23 |
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
|
CI
| |
18/09/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(XSEC:301096) added to S&P Global BMI Index
|
CI
| |
24/08/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
|
CI
| |
23/08/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. authorizes a Buyback Plan.
|
CI
| |
09/08/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
|
CI
| |
27/04/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
|
CI
| |
20/04/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Cash Dividend for 2022, Payable on 04 May 2023
|
CI
| |
28/03/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022
|
CI
| |
12/03/23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
